That post still desperately tries to spin 10.4% YOY revenue growth as 'bad', which is hilarious, particularly knowing RXMD is working to open a second location as we speak. Growth and expansion have been RXMD's business plan for years now, and we see it with every new step forward they take.
Do your due diligence, and posts like that one become comedy gold.
RXMD is growing, and its current stock price is an absolute bargain, though that probably won't last once they move to OTCQB.